Hello, everyone. And how are you this morning? We are scurrying about as we try to hustle the short people off to the schoolhouse. As usual, time is tight (anyone remember Booker T & The MG's?). To get going, yes, we are quaffing still another cup of stimulation and, as always, invite you to join us. Meanwhile, here are a few items of interest. And let us know if you come across one that we would like to know about. Have a great day...
Merck To Spend $90M On Research Institute In California (San Diego Union Tribune)
Glaxo Sells Europe OTC Brands, Except Alli, To Omega (Reuters)
South Korea Approves Generic Viagra (Agence France-Presse)
Shire To Pay Up To $350M For FerroKin Biosciences (Reuters)
UK's NICE Backs Boehringer's Pradaxa For Irregular Heartbeats (Bloomberg News)
Stada's Failed Bids In Russia Belies Growing Pains (Reuters)
CVS Florida Stores Can Remain Open: Appeals Court (Reuters)
Pfizer CEO Says Europe Is Undermining Innovation (Reuters)
EDITOR'S NOTE: Please check this post for updates throughout the morning
steaming coffee pic thx to dleggett on flickr